News

Financial results for the fourth quarter ended Dec. 31, 2008. Diluted earnings per share, excluding specified items, were $1.06, reflecting 14.0% growth, in line with Abbott’s previous forecast.

This new round of financing was completed through TaiGen Biopharmaceuticals Holdings Limited (Cayman), the parent company of TaiGen Biotechnology. The proceeds are to be used primarily for advancing

Mr Bryant will begin employment with Quidel and join the Quidel board on February 2, 2009. Caren Mason will continue in her current capacity as president and CEO

Scott Gottlieb served as FDA Deputy Commissioner for Medical and Scientific Affairs for the period 2005-2007, and prior to that, from 2003-2004, as senior advisor for medical technology

NanoInk, a technology-based company, is specialized in nanometer-scale manufacturing and applications development for life science and semiconductor industries. The company currently owns 140 patents and applications filed worldwide

The data showed that the new regulatory elements can distinguish the estrogenic pharmacological activity exerted by different compounds and allow for more accurate prediction of specific tissue effect.

Under the companies’ collaboration agreement, Curis will receive a $6 million cash payment from Genentech following initiation of this pivotal trial. Genentech expects to evaluate GDC-0449 in approximately

In the first Phase II trial, DM-71 showed statistically significant declines in HbA1c, fructosamine and weight with an excellent safety profile in humans, the company said. This second

Lilly said that it has been co-operating with the government in its investigation since it began in 2004. As part of the resolution, Lilly has agreed to plead